Evidence map›Paper›PMID 33963260›Full record

ArticleScientific reports2021

Collagen fiber regulation in human pediatric aortic valve development and disease.

Cassandra L Clift, Yan Ru Su, David Bichell, Heather C Jensen Smith, Jennifer R Bethard, Kim Norris-Caneda, Susana Comte-Walters, Lauren E Ball, M A Hollingsworth, Anand S Mehta and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Jinlian Xiaodu Decoction Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Cassandra L CliftDepartment of Cell and Molecular Pharmacology, MUSC Proteomics Center, Bruker-MUSC Clinical Glycomics Center of Excellence, Medical University of South Carolina, 173 Ashley Ave, BSB358, Charleston, SC, 29425, USA.
Yan Ru SuDivision of Pediatric Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
David BichellDivision of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Heather C Jensen SmithEppley Institute for Cancer Research and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Jennifer R Bethard
Kim Norris-Caneda
Susana Comte-Walters
Lauren E Ball
M A HollingsworthEppley Institute for Cancer Research and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Anand S MehtaDepartment of Cell and Molecular Pharmacology, MUSC Proteomics Center, Bruker-MUSC Clinical Glycomics Center of Excellence, Medical University of South Carolina, 173 Ashley Ave, BSB358, Charleston, SC, 29425, USA.
Richard R DrakeDepartment of Cell and Molecular Pharmacology, MUSC Proteomics Center, Bruker-MUSC Clinical Glycomics Center of Excellence, Medical University of South Carolina, 173 Ashley Ave, BSB358, Charleston, SC, 29425, USA.
Peggi M AngelDepartment of Cell and Molecular Pharmacology, MUSC Proteomics Center, Bruker-MUSC Clinical Glycomics Center of Excellence, Medical University of South Carolina, 173 Ashley Ave, BSB358, Charleston, SC, 29425, USA. angelp@musc.edu.
Bruker (United States) · USMedical University of South Carolina · USUniversity of Nebraska Medical Center · USVanderbilt University Medical Center · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI James Eudy · 1985 to 2026
$55.0M
Nebraska Center for Nanomedicine- Pilot ProjectsP30GM127200 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI OUPICKY, DAVID · 2018 to 2022
$5.7M
Orbitrap Fusion Lumos ETD Mass SpectrometerS10OD025126 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2018 to 2018
$991k
Simplified Glycan Profiling Workflows of Captured Immune Glycoproteins and CellsU01CA242096 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ANGEL, PEGGI M, DRAKE, RICHARD R. · 2019 to 2021
$818k
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal ProteinsR21CA240148 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ANGEL, PEGGI M · 2019 to 2020
$480k
Structure-Function Relationship of the Extracellular Matrix Proteome in Congenital Aortic Valve StenosisF31HL156524 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CLIFT, CASSANDRA LUCILLE · 2021 to 2021
$35k
American Heart Association 16GRNT31380005Division of Cancer Prevention, National Cancer Institute R21CA240148NCI NIH HHS P30 CA036727NCI NIH HHS U01CA242096NHLBI NIH HHS F31 HL156524NHLBI NIH HHS HL007260NIGMS NIH HHS P30 GM127200NIGMS NIH HHS P30GM127200NIH HHS S10 OD025126NIH Office of the Director S10OD010731South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling GM 103542
6 · The paper itself

Abstract

Congenital aortic valve stenosis (CAVS) affects up to 10% of the world population without medical therapies to treat the disease. New molecular targets are continually being sought that can halt CAVS progression. Collagen deregulation is a hallmark of CAVS yet remains mostly undefined. Here, histological studies were paired with high resolution accurate mass (HRAM) collagen-targeting proteomics to investigate collagen fiber production with collagen regulation associated with human AV development and pediatric end-stage CAVS (pCAVS). Histological studies identified collagen fiber realignment and unique regions of high-density collagen in pCAVS. Proteomic analysis reported specific collagen peptides are modified by hydroxylated prolines (HYP), a post-translational modification critical to stabilizing the collagen triple helix. Quantitative data analysis reported significant regulation of collagen HYP sites across patient categories. Non-collagen type ECM proteins identified (26 of the 44 total proteins) have direct interactions in collagen synthesis, regulation, or modification. Network analysis identified BAMBI (BMP and Activin Membrane Bound Inhibitor) as a potential upstream regulator of the collagen interactome. This is the first study to detail the collagen types and HYP modifications associated with human AV development and pCAVS. We anticipate that this study will inform new therapeutic avenues that inhibit valvular degradation in pCAVS and engineered options for valve replacement.

Indexed as

Aortic ValveAortic Valve StenosisHeart Defects, CongenitalProtein Processing, Post-TranslationalAdolescentChildChild, PreschoolCollagenFemaleHumansHydroxylationInfantInfant, NewbornMaleProteomicsCollagen

Identifiers

PMID33963260
PMCPMC8105334
OpenAlexW3159740549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.